Mitelos and OC Farma Announce Partnership Agreement for OTIBLOCK® ear spray in the Turkish market

Mitelos and OC Farma Announce Partnership Agreement for OTIBLOCK® ear sprayin the Turkish market

 

Cerdanyola, Barcelona (Spain) – Ankara (Turkey); October 16th, 2017: OC Farma, a pharmaceutical company with an experience of more than 20 years and Mitelos, a business to business innovation-driven company, announced that they have entered into a distribution and commercial supply agreement that grants the former the rights to market OTIBLOCK®  ear spray in Turkey.

In turn, Mitelos expands the list of countries in which the product is to be placed on the market imminently, including Malaysia, Singapore, UAE, Saudi Arabia, Kuwait, Australia, New Zealand, etc. after the commercial success achieved in Spain.

OTIBLOCK® ear spray is a new medical device intended to ease ear wax build-up removal and preserve the physiological environment within the external ear canal in order to prevent the further development of outer ear infections.

 

About OC Farma Pharmaceuticals

OC FARMA is an innovative pharmaceutical company with more than twenty years of experience of managing Business Development, Licensing and Regulator Affairs of Original/Generic Pharmaceuticals Biosimilars, MABs, Cosmetics, Dermocosmetics, Dietary supplements and Medical Devices focusing on the Turkish market. For more information, visit www.ocfarma.com.

About Mitelos

Established in 2013 in Barcelona, Mitelos is an independent private company that develops, registers and manufactures medical devices and dietary supplements. Mitelos also provides business development services to third parties in order to help clients achieve their growth-related goals. For more information, visit www.mitelos.com.